The effects of lactic acid bacteria ingestion on inflammation-related serum markers

The effects of lactic acid bacteria ingestion on inflammation-related serum markers - The effects of lactic acid bacteria ingestion on inflammation-related serum markers

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000060707

Enrollment

Registered

2026-02-26

Start date

2026-02-26

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adults

Interventions

Ingestion of lactic acid bacteria powder

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: 1. Subjects who completed a previous study (UMIN000054363) and ingested a high dose of lactic acid bacteria powder 2. Subjects who provided written informed consent prior to participation

Exclusion criteria

Exclusion criteria: 1. milk allergy 2. Subjects who donated 200 mL of blood within 1 month or 400 mL of blood within 3 months 3. Subjects deemed unsuitable for the study by the principal investigator for any other reason

Design outcomes

Primary

Measure	Time frame
Serum IL-10 levels	—

Secondary

Measure	Time frame
Serum IL-6, IL-4, IGF-1 levels	—

Countries

Japan

Contacts

Public ContactAya Yoshimura

Meiji Co., Ltd. R&D Division

aya.yoshimura.aa@meiji.com+81-42-632-5847

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026